FibroGen (0IL8.L) Stock Price

$6.75 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    5
  • Fundamental

    3
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on FibroGen, AI stock picks, stock alerts and much more.

Sign up

0IL8.L AI Stock Analysis

AI stock analysis for 0IL8.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like FibroGen (0IL8.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

FibroGen (0IL8.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of FibroGen (0IL8.L), currently trading at $6.75, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0IL8.L

LSE
  • FibroGen, Inc.

  • Symbol

    0IL8.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    20.9M

0IL8.L Alternative Data

Web Traffic

FibroGen receives an estimated 3951 monthly visitors to fibrogen.com.

  • Web Traffic

    3951

  • Change from Previous Month

    1.4%

  • 3 Month Change

    33.7%

  • YoY Change

    33.7%

Twitter Followers

FibroGen has 991 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    991

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0%

  • YoY Change

    0%

Job Postings

FibroGen currenly has an estimated 1 open job postings.

  • Job Postings

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

FibroGen has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

16,917 are following FibroGen on LinkedIn, up by 0.4% over the last month.

  • LinkedIn Followers

    16917

  • Daily Change

    0.4%

  • 1 Month Change

    0.4%

  • 3 Month Change

    0.9%

Business Outlook

According to employee reviews, the business outlook among employees at FibroGen is 41 out of 100 (neutral).

  • Business Outlook

    41

  • Change from Previous Month

    0%

  • 3 Month Change

    16.3%

  • YoY Change

    16.3%

LinkedIn Employees

According to LinkedIn, FibroGen has 313 employees, down by -2.2% over the last month.

  • LinkedIn Employees

    313

  • Daily Change

    2.2%

  • 1 Month Change

    2.2%

  • 3 Month Change

    3.4%

News Mentions

FibroGen was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

  • YoY Change

    100%

0IL8.L Financials

0IL8.L Key Metrics
  • Total Revenue

    $2.7M

  • Net Income

    $4.6M

  • Earnings per Share

    $0.05

  • Free cash flow

    $2.7M

  • EBITDA

    -$14.2M

  • EBITDA Ratio

    -5.17707

  • Total Assets

    $165.2M

0IL8.L 2-year Revenue & Income
0IL8.L 2-year Free Cash Flow

0IL8.L Technicals

0IL8.L SMA
0IL8.L RSI

FAQ

What's the current price of FibroGen (0IL8.L) Stock?
The price of an FibroGen (0IL8.L) share is $6.75.

What's the market cap of FibroGen?
The current market cap of FibroGen is 20.9M.

Should I buy or sell 0IL8.L?
FibroGen shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, FibroGen is better viewed as a hold or accumulate position while waiting for further developments.

Is FibroGen a good investment?
The current analysis of FibroGen's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in FibroGen's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy FibroGen (0IL8.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for FibroGen stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to FibroGen (0IL8.L) that investors often compare it to?
FibroGen (0IL8.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.

What is the forecast for FibroGen's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast FibroGen's stock price to be around $6.55 in 2026. Starting from the current price of $6.75, this represents a 3% change in price, indicating a neutral outlook for the stock.

How to buy FibroGen (0IL8.L) Stock?
FibroGen stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy FibroGen shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.